High rates of hepatocellular carcinoma within two years of starting treatment for chronic hepatitis C with direct antiviral agents but not with PEG-interferon/ Ribavirin (HORRID Study)
2018 ◽
Vol 1
(suppl_2)
◽
pp. 390-390
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 112
(6)
◽
pp. 828-832
◽
Keyword(s):